Improved Glycaemic Variability and Basal Insulin Dose Reduction During a Running Competition in Recreationally Active Adults with Type 1 Diabetes-A Single-centre, Prospective, Controlled Observational Study
Overview
Authors
Affiliations
Introduction: To investigate the glycaemic response, macronutrient intake and insulin management in people with type 1 diabetes (T1D) compared to healthy individuals around a running competition.
Material And Methods: This was a single-centre, prospective, controlled observational study performed in individuals with T1D and healthy people. 24 people (12 T1D) were included in this study (age: T1D 41±12 vs. healthy 38±6 years, females: 3 vs. 6, BMI: 25.53.0 vs. 22.9±2.8 kg/m2). Both groups received an intermittently scanned continuous glucose monitoring (isCGM; FreeStyle Libre 1, Abbott, USA) system to assess glycaemia 24 hours before, during and 24 hours after a running competition. During this period, participants recorded their food intake and insulin administration. Data were analysed via ANOVA and mixed model analyses with post-hoc testing (p≤0.05).
Results: For overall glycaemic ranges in comparison of groups, significant differences were found for time in range (T1D 63±21% vs. healthy 89±13%, p = 0.001), time above range (TAR) 1 (T1D 21±15% vs. healthy 0±0%, p<0.001) and TAR 2 (T1D 8 [0-16%] vs. healthy 0±0%, p<0.001). When glycaemic variability was assessed, people with T1D had a higher glycaemic variability compared to healthy individuals (p<0.0001). Basal insulin dose was significantly reduced when compared against the regular pre-study basal insulin dose (pre-study 22±6 vs. pre-competition day 11±9 (-50±41%), p = 0.02; competition day 15±5 (-32± 1%)).
Conclusion: People with T1D have impaired glucose responses around a running competition compared to healthy individuals. However, basal insulin dose reductions were sufficient to prevent further dysglycaemia.
Clinical Trial Id: drks.de; DRKS00019886.
Dynamic of Glucose Homeostasis in Virtual Patients: A Comparison between Different Behaviors.
Alonso-Bastida A, Adam-Medina M, Posada-Gomez R, Salazar-Pina D, Osorio-Gordillo G, Vela-Valdes L Int J Environ Res Public Health. 2022; 19(2).
PMID: 35055537 PMC: 8775377. DOI: 10.3390/ijerph19020716.
Vartak V, Chepulis L, Driller M, Paul R Sports Med Open. 2021; 7(1):29.
PMID: 33914197 PMC: 8085176. DOI: 10.1186/s40798-021-00319-5.
Moser O, Dietrich M, McCarthy O, Bracken R, Eckstein M Diabetes Obes Metab. 2020; 22(10):1714-1721.
PMID: 32383791 PMC: 7540083. DOI: 10.1111/dom.14083.